|The DDX53 n/a (Catalog #MBS6011033) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The DDX53 (CAGE, Probable ATP-dependent RNA Helicase DDX53, Cancer-associated Gene Protein, Cancer/Testis Antigen 26, CT26, DEAD Box Protein 53, DEAD Box Protein CAGE) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s DDX53 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
Suitable for use in Western Blot. Researchers should empirically determine the suitability of the DDX53 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:
MSHWAPEWKR AEANPRDLGA SWDVRGSRGS GWSGPFGHQG PRAAGSREPP LCFKIKNNMV GVVIGYSGSK IKDLQHSTNT KIQIINGESE AKVRIFGNRE MKAKAKAAIE TLIRKQESYN SESSVDNAAS QTPIGRNLGR NDIVGEAEPL SNWDRIRAAV VECEKRKWAD LPPVKKNFYI ESKATSCMSE MQVINWRKEN FNITCDDLKS GEKRLIPKPT CRFKDAFQQY PDLLKSIIRV GILKPTPIQS QAWPIILQGI DLIVVAQTGT GKTLSYLMPG FIHLDSQPIS REQRNGPGML VLTPTRELAL HVEAECSKYS YKGLKSICIY GGRNRNGQIE DISKGVDIII ATPGRLNDLQ MNNSVNLRSI TYLVIDEADK MLDMEFEPQI RKILLDVRPD RQTVMTSATW PDTVRQLALS YLKDPMIVYV GNLNLVAVNT VKQNIIVTTE KEKRALTQEF VENMSPNDKV IMFVSQKHIA DDLSSDFNIQ GISAESLHGN SEQSDQERAV EDFKSGNIKI LITTDIVSRG LDLNDVTHVY NYDFPRNIDV YVHRVGYIGR TGKTGTSVTL ITQRDSKMAG ELIKILDRAN QSVPEDLVVM AEQYKLNQQK RHRETRSREP GQRRKEFYFL S.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Full length human DDX53, aa1-631 (AAH67878.1). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing DDX53 are readily searchable from our website. Different antibodies against the same target such as DDX53 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.